Gastroretentive Pulsatile Release Tablets of Lercanidipine HCl: Development, Statistical Optimization, and In Vitro and In Vivo Evaluation

Table 6

Comparison of predicted and observed responses for the statistically optimized formulation FP 14.

Formulation	Response	Observed	Predicted	Relative error (%)
FP 14	Drug release lag time (, h)	5.5	6.00	8.3
	% drug release at 7 h ()	77.07	75.71	1.71
	% drug release at 12 h ()	98.95	101.81	2.80